Skip to content

Gilead Sciences GILD Business Segments — Selling, general and administrative expenses

Similar metrics at other companies

Concentrix Corporation logo
CNXCReportable Segment — Selling, general and administrative expenses
$519.47M+7.2%
Century Aluminum logo
CENXReportable Segment — Selling, general and administrative expenses
$25.8M+106%
Crinetics Pharmaceuticals logo
CRNXReportable Segment — Selling, General and Administrative Expense
$50.83M+43.1%
YETI Holdings, Inc. logo
YETIReportable Segment — Selling, general, and administrative expenses
$197.77M+9.8%
AdvanSix logo
ASIXReportable Segment — Selling, general and administrative expenses
$22.52M-3.8%
Twist Bioscience Corporation logo
TWSTReportable Segment — Selling, general and administrative expenses
$59.26M+25.3%

Other financials

Income statement

See full
Revenue$7.0B+4.4%
Gross profit$5.5B+7.6%
Operating income$2.6B+15.6%
Net income$2.0B+53.7%
EPS (diluted)$1.61+54.8%

Balance sheet

See full
Cash & equivalents$7.6B-3.8%
Total debt$22.2B-11.1%
Total equity$23.5B+22.7%
Total assets$56.3B-0.3%

Cash flow

See full
Operating cash flow$2.5B+44.8%
CapEx$117.0M+12.5%
Free cash flow$2.4B+46.8%

Valuation

See full
Market cap$153.76B+13.9%
Enterprise value$168.3B+10.7%
P/E16.7×-5.9×
P/S5.2×+0.5×

Profitability

See full
Gross margin79.4%+1.1pp
Operating margin34.9%+6.3pp
Net margin31%+10.2pp
FCF margin34.4%+0.1pp

Returns & leverage

See full
Return on equity43.2%+10.7pp
Debt / equity0.9×-0.4×
Current ratio+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's business segments — selling, general and administrative expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Gilead Sciences's business segments — selling, general and administrative expenses?
Gilead Sciences (GILD) reported business segments — selling, general and administrative expenses of $1.45B in Q1 2026.
How has Gilead Sciences's business segments — selling, general and administrative expenses changed year-over-year?
Gilead Sciences's business segments — selling, general and administrative expenses increased by 15.3% year-over-year, from $1.26B to $1.45B.
What is the long-term trend for Gilead Sciences's business segments — selling, general and administrative expenses?
Over 3 years (2022 to 2025), Gilead Sciences's business segments — selling, general and administrative expenses has grown at a 0.6% compound annual growth rate (CAGR), from $5.67B to $5.77B.
What does business segments — selling, general and administrative expenses mean?
This metric represents the aggregate of all selling, marketing, and general administrative expenses required to support the company's operations. It serves as a primary measure of the non-production operating costs necessary to sustain the business and drive revenue. Investors use this to evaluate the company's overall operating leverage and cost discipline.